Surgical & Medical Instruments & Apparatus · DE · CIK 1674632
Develops and commercializes the iLet Bionic Pancreas for insulin-requiring people with diabetes
Comparable business profile · signals at a glance
In the 90 days to Mar 4, 2026: 5 sold $1.1M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 4, 2026 | Hopman MarkChief Commercial Officer | Sell | 353 | $11.57 | $4K |
| Mar 2, 2026 | Saint SeanPresident & CEO | Sell | 3,384 | $12.36 | $42K |
| Mar 2, 2026 | Feider StephenChief Financial Officer | Sell | 1,428 | $12.36 | $18K |
| Mar 2, 2026 | Mensinger MikeChief Product Officer | Sell | 1,064 | $12.36 | $13K |
| Mar 2, 2026 | Russell Steven JonChief Medical Officer | Sell | 1,026 | $12.36 | $13K |
| Mar 2, 2026 | Hopman MarkChief Commercial Officer | Sell | 834 | $12.36 | $10K |
| Jan 6, 2026 | Mensinger MikeChief Product Officer | Sell | 2,200 | $30.10 | $66K |
| Jan 2, 2026 | Feider StephenChief Financial Officer | Sell | 20,000 | $29.53 | $591K |
| Jan 2, 2026 | Mensinger MikeChief Product Officer | Sell | 7,200 | $29.56 | $213K |
| Jan 2, 2026 | Mensinger MikeChief Product Officer | Sell | 600 | $30.20 | $18K |
| Dec 4, 2025 | Hopman MarkChief Commercial Officer | Sell | 2,061 | $30.66 | $63K |
| Dec 2, 2025 | Saint SeanPresident & CEO | Sell | 3,278 | $29.34 | $96K |
| Dec 2, 2025 | Feider StephenChief Financial Officer | Sell | 1,427 | $29.34 | $42K |
| Dec 2, 2025 | Mensinger MikeChief Product Officer | Sell | 1,063 | $29.34 | $31K |
| Dec 2, 2025 | Russell Steven JonChief Medical Officer | Sell | 1,025 | $29.34 | $30K |
| Dec 2, 2025 | Hopman MarkChief Commercial Officer | Sell | 856 | $29.34 | $25K |
| Dec 1, 2025 | Lezack AdamDirector | Sell | 906 | $29.35 | $27K |
| Dec 1, 2025 | Palasis MariaDirector | Sell | 906 | $29.33 | $27K |
| Dec 1, 2025 | Palasis MariaDirector | Sell | 500 | $29.96 | $15K |
| Dec 1, 2025 | Lezack AdamDirector | Sell | 500 | $29.91 | $15K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.